Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 5, 2009, Pages 909-916

  Ricci, Vito ^a   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

MDR; RamA; RamR

Indexed keywords

AMIKACIN; AMPICILLIN; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; CYCLOHEXANE; HEXANE; HOE 33342; KANAMYCIN; NALIDIXIC ACID; PROTEIN ACRB; PROTEIN MARA; PROTEIN RAMA; PROTEIN RAMR; PROTEIN ROB; PROTEIN SOXS; TETRACYCLINE; TRICLOSAN; UNCLASSIFIED DRUG;

AGAR DILUTION; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA SEQUENCE; EFFUSION; GENE INACTIVATION; GENETIC COMPLEMENTATION; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MUTANT; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; WILD TYPE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BENZIMIDAZOLES; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC COMPLEMENTATION TEST; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; SALMONELLA TYPHIMURIUM; SELECTION (GENETICS); TRANS-ACTIVATORS;

EID: 64649086925     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp054     Document Type: Article

References (30)

1. Fabrega A, Sanchez-Cespedes J, Soto S et al. Quinolone resistance in the food chain. Int J Antimicrob Agents 2008; 31: 307-15.
2. Wain J, Kidgell C. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever. Trans R Soc Trop Med Hyg 2004; 98: 423-30.
3. Bronzwaer SL, Cars O, Buchholz U et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-82.
4. Meakins S, Fisher IS, Berghold C et al. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: A report from the Enter-net International Surveillance Network. Microb Drug Resist 2008; 14: 31-5.
5. Randall LP, Cooles SW, Osborn MK et al. Antibiotic resistance genes, integrons and multiple antibiotic resistance in thirty-five serotypes of Salmonella enterica isolated from humans and animals in the UK. J Antimicrob Chemother 2004; 53: 208-16.
6. Wain J, Diem Nga LT, Kidgell C et al. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 2003; 47: 2732-9.
7. Piddock LJ, White DG, Gensberg K et al. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44 3118-21.
8. Giraud E, Cloeckaert A, Kerboeuf D et al. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44: 1223-8.
9. Baucheron S, Tyler S, Boyd D et al. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium phage type DT104. Antimicrob Agents Chemother 2004; 48: 3729-35.
10. George AM, Hall RM, Stokes HW. Multidrug resistance in Klebsiella pneumoniae: A novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 1995; 141: 1909-20.
11. Chollet R, Chevalier J, Bollet C et al. RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob Agents Chemother 2004; 48: 2518-23.
12. van der Straaten T, Janssen R, Mevius DJ et al. Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2004; 48: 2292-4.
13. Schneiders T, Amyes SGB, Levy SB. Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 2003; 47 2831-7.
14. Abouzeed YM, Baucheron S, Cloeckaert A. ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2008; 52: 2428-34.
15. Yassien MA, Ewis HE, Lu CD et al. Molecular cloning and characterization of the Salmonella enterica serovar Paratyphi B rma gene, which confers multiple drug resistance in Escherichia coli. Antimicrob Agents Chemother 2002; 46: 360-6.
16. Ricci V, Tzakas P, Buckley A et al. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 2006; 50: 38-42.
17. Bailey AM, Paulsen IT, Piddock LJV. RamA confers MDR in Salmonella Typhimurium via increased expression of acrB which is inhibited by chlorpromazine. Antimicrob Agents Chemother 2008; 52: 3604-11.
18. Nikaido E, Yamaguchi A, Nishino K. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem 2008; 283: 24245-53.
19. Wray C, Sojka WJ. Experimental Salmonella typhimurium in calves. Res Vet Sci 1978; 25: 139-43.
20. Piddock LJV, Whale K, Wise R. Quinolone resistance in salmonella: clinical experience. Lancet 1990; 335: 1459.
21. Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008; 62: 256-78.
22. Aarestrup F, Wiuff MC, Mølbak K et al. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003; 47: 827-9.
23. Wain J, Hoa N, Nguyen T et al. Quinolone-resistant Salmonella typhi in Vietnam: Molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997; 25: 1404-10.
24. Aono R, Kobayashi M, Nakajima H et al. A close correlation between improvement of organic solvent tolerance levels and alteration of resistance toward low levels of multiple antibiotics in Escherichia coli. Biosci Biotechnol Biochem 1995; 59: 213-8.
25. Webber MA, Randall LP, Cooles S et al. Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2008; 62: 83-91.
26. Buckley A, Webber MA, Cooles S et al. The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell Microbiol 2006; 8: 847-56.
27. Eaves DJ, Ricci V, Piddock LJV. Expression of acrB, acrF, acrB, marA and soxS in Salmonella enterica serovar Typhimurium: Role in multiple antibiotic resistance. Antimicrob Agents Chemother 2004; 48: 1145-50.
28. Bailey A, Webber MA, Piddock LJV. Medium plays a role in determining expression of acrB, marA and soxS in Escherichia coli. Antimicrob Agents Chemother 2006; 50: 1071-4.
29. Piddock LJ, Griggs DJ, Hall MC et al. Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob Agents Chemother 1993; 37: 662-6.
30. Alekshun MN, Levy SB, Mealny TR et al. The crystal structure of MarR, a regulator of antibiotic resistance, at 2.3 Å resolution. Nat Struct Biol 2001; 8: 710-4.